MERIT Announces Successful FDA Inspection

We are very proud of this result. A no‑483 outcome is a testament to the discipline, expertise, and dedication of our ...

AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities

AINewsWire Editorial Coverage: Pharmaceutical manufacturing is undergoing a structural shift as regulators demand higher standards for contamination control, data integrity and operational ...

Robotics and AI in Drug Manufacturing: May Unlock Efficiency Gains, Long-Term Value

TechForce Robotics contributes to this evolution by embedding AI-driven SOP intelligence and real-time monitoring into its robotic systems. This enables compliance to function as an integrated, ...
Forbes

Why The FDA And Others Should Use Blockchain To Guarantee Authenticity

Chris is the CTO and Co-Founder of Scientist.com, a Research Platform helping drug discovery researchers develop new therapies. The FDA’s adoption of electronic submissions raised concerns about data ...

U.S. FDA issues 4 observations to U.S. facility of Granules arm

The U.S. Food and Drug Administration (U.S. FDA) has issued four Form 483 observations to Granules India subsidiary Granules Pharmaceuticals Inc facility in Virginia, US.
Hosted on MSN

FDA Takes Action Against Third-Party Testing Labs Over Falsified Data

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has issued General Correspondence Letters to two third-party testing companies in China after uncovering falsified or otherwise invalid ...

Granules Life Sciences’ Hyderabad plant gets VAI inspection classification from U.S. FDA

Granules Life Sciences' Hyderabad plant receives VAI classification from U.S. FDA after successful cGMP inspection.